Why the study?
Despite evidence of increased mortality and structural valve degeneration after surgical aortic valve replacement, the clinical impact of prosthesis-patient mismatch in patients undergoing TAVI remains unclear.
This review summarizes the definition, incidence, prognostic implications, and prevention strategies for prosthesis-patient mismatch following transcatheter aortic valve implantation.
Prosthesis-patient mismatch (PPM) is present when the effective area of a prosthetic valve inserted into a patient is inferior to that of a normal human valve; the hemodynamic consequence of a valve too small compared with the size of the patient's body is the generation of higher than expected transprosthetic gradients. Despite evidence of increased risk of short- and long-term mortality and of structural valve degeneration in patients with PPM after surgical aortic valve replacement, its clinical impact in patients subject to transcatheter aortic valve implantation (TAVI) is yet unclear. We aim to review and update on the definition and incidence of PPM after TAVI, and its prognostic implications in the overall population and in higher-risk subgroups, such as small aortic annuli or valve-in-valve procedures. Last, we will focus on the armamentarium available in order to reduce risk of PPM when planning a TAVI procedure.
No takes yet. Share an insight, caveat, or question.
Leone et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: